LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2020 Results - Earnings Call Transcript

Ligand Pharmaceuticals Incorporated (LGND) Q3 2020 Earnings Conference Call October 30, 2020 8:30 AM ET Company Participants Patrick O'Brien - Investor Relations John Higgins - Chief Executive Officer Matt Korenberg - Executive Vice President, Finance & Chief Financial Officer Matt Foehr - President & Chief Operating Officer Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Balaji Prasad - Barclays Joe Pantginis - H.C. Wainwright Scott Henry - Roth Capital Dana Flanders - Guggenheim Securities Presentation Operator [Call starts abruptly] and instructions and how to do so will be given at the appropriate time. If you would like to view the presentation in a full screen view, click the full screen button in the lower right-hand corner of your screen. Press escape key on your keyboard to return to your original view. For optimal viewing and participation, please disable your pop-up blockers. And finally, should you need technical assistance, as

For further details see:

Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2020 Results - Earnings Call Transcript